Brief: Baudax Bio Announces Pricing Offering Of Aggregate Of 11.8 Million Shares Of Common Stock & Accompanying Common Stock Purchase Warrants At $0.525 Per Share
30/08/2022 03:10
Aug 29 (Reuters) - Baudax Bio Inc BXRX.O :
* BAUDAX BIO ANNOUNCES PRICING OF $6.2 MILLION PUBLIC
OFFERING
* BAUDAX BIO INC - ANNOUNCED PRICING OF ITS PUBLIC OFFERING
OF AN
AGGREGATE OF 11.8 MILLION SHARES OF COMMON STOCK & ACCOMPANYING
COMMON STOCK PURCHASE WARRANTS AT A IPO OF $0.525 PER SHARE
* BAUDAX BIO- PRICING OFFERING OF AGGREGATE OF 11.8 MILLION
SHARES
OF COMMON STOCK & ACCOMPANYING COMMON STOCK PURCHASE WARRANTS AT
$0.525 PER SHARE
Source text for Eikon: ID:nGNXbsnRcZ
Further company coverage: BXRX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Baudax Bio
See all newsBrief: Baudax Bio On Feb 22, Filed Voluntary Petition Under Chapter 11 Of U.S. Bankruptcy Code
Brief: Baudax Bio Says Substantial Doubt Exists About Ability To Continue As A Going Concern For Next Twelve Months
Baudax Bio Inc expected to post a loss of 53 cents a share - Earnings Preview
Brief: Baudax Bio Says Phase 1/2a Clinical Study of TI-168 In Hemophilia A with FVIII Inhibitors Projected to Begin Q1 2024
Brief: Baudax Bio Inc - On October 5, 2023, Board Of Directors Of Company Appointed Natalie Mcandrew As Interim Chief Financial Officer